References
- Warner-Schmidt JL, Vanover KE, Chen WY et al. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA108(22), 9262–9267 (2011).
- Rush AJ, Trivedi MH, Wisniewski SR et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry163(11), 1905–1917 (2006).
- Machado-Vieira R, Salvadore G, Luckenbaugh DA, Manji HK, Zarate CA Jr. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J. Clin. Psychiatry69(6), 946–958 (2008).
- Forbes EE, Hariri AR, Martin SL et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am. J. Psychiatry166(1), 64–73 (2009)
- Garriock HA, Kraft JB, Shyn SI et al. A genomewide association study of citalopram response in major depressive disorder. Biol. Psychiatry67(2), 133–138 (2010).
- Vreeburg SA, Hartman CA, Hoogendijk WJ et al. Parental history of depression or anxiety and the cortisol awakening response. Br. J. Psychiatry197(3), 180–185 (2010).
- Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry3(6), 508–511 (1998).
- Müller N, Schwarz MJ, Dehning S et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry11(7), 680–684 (2006).
- Svenningsson P, Chergui K, Rachleff I et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science311(5757), 77–80 (2006).
- Warner-Schmidt JL, Chen EY, Zhang X et al. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol. Psychiatry68(6), 528–535 (2010).
- Warner-Schmidt JL, Flajolet M, Maller A et al. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J. Neurosci.29(6), 1937–1946 (2009).
- DeVeaugh-Geiss AM, West SL, Miller WC, Sleath B, Gaynes BN, Kroenke K. The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med.11(5), 732–741 (2010).
- Leuchter AF, Husain MM, Cook IA et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol. Med.40(2), 239–251 (2010).
- Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience135(3), 659–678 (2005).